CDKN2A and tongue cancer: While several biomarkers—including p16, FGFR3 mutations, and microRNA profiles—have emerged as promising candidates for stratifying HPV-positive tongue cancers, it is important to acknowledge that these findings are primarily derived from retrospective studies with limited sample sizes and heterogeneous methodologies.